Hematologist and Medical Oncologist, Saskatchewan Cancer Centre
Assistant Professor Department of Medicine
Medical Oncology, University of Saskatchewan
Dr. Mita Manna, a distinguished Hematologist and Medical Oncologist, serves as a source of expertise and compassion at the forefront of cancer care in Saskatchewan. Currently, she holds the esteemed position of Medical Oncologist at the Saskatchewan Cancer Centre in Saskatoon, concurrently serving as Assistant Professor within the Department of Medicine at the University of Saskatchewan.
Dr. Manna’s professional focus revolves around breast and thoracic malignancies, areas where her depth of knowledge and dedication shine brightly. As the Provincial Disease Site Group Chair for Breast Malignancies and the Multidisciplinary Tumor Board Chair for Breast Malignancies, she orchestrates a symphony of collaborative efforts aimed at optimizing patient outcomes.
Beyond her clinical endeavors, Dr. Manna is deeply invested in medical education, nurturing the next generation of healthcare professionals. Her commitment extends to patient education, empowering individuals to navigate their cancer journey with informed decision-making and resilience.
Recently, Dr. Manna’s unwavering advocacy led to a groundbreaking development in cancer care: the implementation of essential genetic testing for breast cancer patients in Saskatchewan. Recognizing the critical importance of timely access to genetic information, she spearheaded efforts to streamline the testing process, ensuring that patients receive vital insights promptly.
Her visionary approach culminated in the successful acquisition of a substantial grant, enabling the launch of a pilot mainstream genetic testing program. This initiative not only addresses the pressing need for efficient testing but also underscores Dr. Manna’s proactive stance in advancing patient-centered care.
Dr. Manna’s transformative impact extends beyond the confines of her clinical practice, resonating throughout the healthcare landscape of Saskatchewan – and across Canada.
Through her tireless advocacy, innovative solutions, and unwavering dedication to research, she continues to champion better, more effective care for breast cancer patients